The evolving story of Chlamydia-induced reactive arthritis

Current Opinion in Rheumatology

Volumn 22, Issue 4, 2010, Pages 424-430

  Carter, John D ^a   Hudson, Alan P ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chlamydia pneumoniae; Chlamydia trachomatis; Drug therapy; Reactive arthritis; Reiter's syndrome

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXYCYCLINE; ETANERCEPT; HLA B27 ANTIGEN; LYMECYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RIFAMPICIN; SALAZOSULFAPYRIDINE; TETRACYCLINE; TUMOR NECROSIS FACTOR INHIBITOR;

ANTIBACTERIAL ACTIVITY; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIAGNOSTIC VALUE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG RESPONSE; HUMAN; INCIDENCE; MONOTHERAPY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW;

ANTI-BACTERIAL AGENTS; ARTHRITIS, REACTIVE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; HUMANS;

EID: 77953479831     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32833a43a2     Document Type: Review

References (74)

1. Braun J, Tuszewski M, Eggens U, et al. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol 1997; 24:1092-1100.
2. Granfors K, Jalkanen S, Toivanen P, et al. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. 1992; 19:500.
3. Nikkari S, Merilahti-Palo R, Saario R, et al. Yersinia-triggered reactive arthritis: use of polymerase chain reaction and immunocytochemical in the detection of bacterial components from synovial specimens. Arthritis Rheum 1992; 35:682-687.
4. Nikkari S, Rantakokko K, Ekman P, et al. Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas-chromatography-mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum 1999; 42:84-89.
5. Gerard HC, Branigan PJ, Schumacher HR Jr, Hudson AP. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 1 998; 25:734-742.
6. Groseclose SL, Zaidi AA, Delisle SJ, et al. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999; 26:339-344.
7. Rich E, Hook EW 3rd, Alarcon GS, Moreland LW. Reactive arthritis in patients attending and urban sexually transmitted disease clinic. Arthritis Rheum 1996; 39:1172-1177.
8. Doran MF, Pond GR, Crowson CS, et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002; 46:625-631.
9. Soderlin MK, Borjesson O, Kautiainen H, et al. Annual incidence of inflammatory joint disease in a population based study in southern Sweden. Ann Rheum Dis 2002; 61:911-915.
10. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 2009; 35:21-44.
11. Braun J, Kingsley G, van der HeijdeD, et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations of reactive arthritis: results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6. J Rheumatol 2000; 27:2185-2192.
12. Boyer GS, Templin DW, Bowler A, et al. A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study: has the classic case misled us? Arch Intern Med 1997; 157:2111-2117.
13. Carter JD, Gerard HC, Espinoza LR, et al. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009; 60:1311-1316.
14. Gordon FB, Quan AL, Steinman TI, Philips RN. Chlamydial isolates from Reiter's syndrome. Br J Vener Dis 1973; 49:376-378.
15. Keat A, Thomas B, Dixcey J, et al. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1987; 1:72-74.
16. Norton WL, Lewis D, Ziff M. Light and electron microscopic observation on the synovitis of Reiter's disease. Arthritis Rheum 1966; 9:747-757.
17. Ishikawa H, Ohno O, Yamasaki K, et al. Arthritis presumably caused by Chlamydia in Reiter's syndrome: case report with electron microscopic studies. J Bone Joint Surg Am 1986; 68:777-779.
18. Gerard HC, Fomicheva E, Whittum-Hudson JA, Hudson AP. Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae ele mentary bodies to host cells. Microb Pathog 2008; 44:279-285.
19. Schumacher HR, Magge S, Cherian PV, et al. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome: immunocytochemical identification of chlamydial antigen in patients with early disease. Arthritis Rheum 1988; 31:937-946.
20. Nanagara R, Li F, Beutler AM, et al. Alteration of C. trachomatis biological behavior in synovial membranes: suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum 1995; 38:1410-1417.
21. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon gamma mediated persistent C. trachomatis infection. Proc Natl Acad Sci USA 1993; 90:3998-4002.
22. Gerard HC, Schumacher HR, El-Gabalawy H, et al. Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog 2000; 29:17-24.
23. Gerard HC, Whittum-Hudson JA, Schumacher HR, Hudson AP. Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb Pathog 2004; 36:35-39.
24. HessS, Peters J, Bartling G, et al. More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation. Cell Microbiol 2003; 5:785-795.
25. Gerard HC, Wang Z, Whittum-Hudson JA, et al. Cytokine and chemokine mRNA produced in synvovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol 2002; 29:1827-1835.
26. Telyatnikova N, Hill Gaston JS. Prior exposure to infection with Chlamydia pneumoniae can influence the T-cell-mediated response to Chlamydia trachomatis. FEMS Immunol Med Microbiol 2006; 47:190-198.
27. Wilkinson NZ, Kingsley GH, Jones HW, et al. The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritidies using a nested, broad-range polymerase chain reaction. Rheumatology 1999; 38:260-266.
28. Schumacher HR, Arayssi T, Crane M, et al. Chlamydia trachomatis nucleic acids can be found in synovium of some asymptomatic volunteers. Arthritis Rheum 1999; 42:1281-1284.
29. Olmez N, Wang GF, Li Y, et al. Chlamydial nucleic acids in synovium in osteoarthritis: what are the implications? J Rheumatol 2001; 28:1874-1880.
30. SialaM, JaulhacB, GdouraR, et al. Analysis of bacterial DNA in synovial tissue of Tunisian patients with reactive and undifferentiated arthritis by broad-range PCR, cloning and sequencing. Arthritis Res Ther 2008; 10:R40.
31. Morris R, Metzger AL, Bluestone R, Terasaki PI. HL-A W27: a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med 1974; 290:554-556.
32. Khan MA. Clinical application of the HLA-B27 test in rheumatic diseases: a current perspective. Arch Intern Med 1980; 140:1097-1098.
33. Inman RD, Johnston ME, Hodge M, et al. Postdysenteric reactive arthritis. A clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum 1988; 31:1377-1383.
34. Mattila L, Leirisalo-Repo M, Koskimies S, et al. Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol 1994; 33:1136-1141.
35. Mattila L, Leirisalo-Repo M, Pelkonene P, et al. Reactive arthritis following an outbreak of Salmonella bovismorbificans infection. J Infect 1998; 36:289-295.
36. Hannu T, Kauppi M, Tuomala M, et al. Reactive arthritis following an outbreak of Campylobacter jejuni infection. J Rheumatol 2004; 31:528-530. (Pubitemid 38337614)
37. Kvien TK, Gaston JS, Bardin T, et al. Three-month treatment of reactive arthritis with azithromycin: a EULAR double-blind, placebo-controlled study. Ann Rheum Dis 2004; 63:1113-1119.
38. Townes JM, Deodhar AA, Laine ES, et al. Reactive arthritis following cultureconfirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Ann Rheum Dis 2008; 67:1689-1696.
39. RohekarS, Tsui FW, Tsui HW, et al. Symptomatic acute reactive arthritis after an outbreak of Salmonella. J Rheumatol 2008; 35:1599-1602.
40. Pope JE, Krizova A, Garg AX, et al. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 2007; 37:48-55.
41. Sonkar GK, Usha. Role of HLA B27 in diagnosis of seronegative spondyloarthropathies. Indian J Pathol Microbiol 2007; 50:908-913.
42. Schiellerup P, Krogfelt KA, Locht H. A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27. J Rheumatol 2008; 35:480-487.
43. Girschick HJ, Guilherme L, Inman RD, et al. Bacterial triggers and autoimmune rheumatic diseases. Clin Exp Rheumatol 2008; 26 (1 Suppl 48):S12-S17.
44. Perry LL, Feilzer K, Caldwell HD. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and-independent pathways. J Immunol 1997; 158:3344.
45. Yang X, Gartner J, Zhu L, et al. IL-10 knockout mice show enhanced Th1-like protective immunity and absent granulomas formation following Chlamydia trachomatis lung infection. J Immunol 1999; 162:1010-1017.
46. Quinn TC, Gaydos CA. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Am Heart J 1999; 138 (5 Pt 2):S507-S511.
47. TakanoR, Yamaguchi H, SugimotoS, et al. Cytokine response of lymphocytes persistent infected with Chlamydia pneumoniae. Curr Microbiol 2005; 50:160-166.
48. Ishihara T, Aga M, Hino K, et al. Inhibition of Chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha. Biomed Res 2005; 26:179-185.
49. Inman RD, Chiu B. Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia-induced arthritis in rats. Arthritis Rheum 2006; 54:499-507.
50. Gerard HC, Stanich JA, Whittum-Hudson JA, et al. Patients with Chlamydiaassociated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microb Pathog 2010; 48:62-68.
51. Mittal A. Serovar distribution of Chlamydia trachomatis isolates collected from the cervix: use of the polymerase chain reaction and restriction endonuclease digestion. Br J Biomed Sci 1998; 55:179-183.
52. Workowski KA, Stevens CE, Suchland RJ, et al. Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar. Clin Infect Dis 1994; 19:756-760.
53. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996; 39:2021-2027.
54. Egsmose C, Hansen TM, Andersen LS, et al. Limited effect of sulfasalazine treatment in reactive arthritis: a randomized double blind placebo controlled trial. Ann Rheum Dis 1997; 56:32-36.
55. Rihl M, Gu J, Baeten D, et al. Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gamma. Ann Rheum Dis 2004; 63:1673-1676.
56. Braun J, Yin Z, Spiller I, et al. Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 1999; 42:2039-2044.
57. Thiel A, Wu P, Lauster R, et al. Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry. Arthritis Rheum 2000; 43:2834-2842.
58. Yin Z, Braun J, Neure L, et al. Crucial role of interleukin-10/ interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 1997; 40:1788-1797.
59. Schrafranski MD. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatol Int 2010; 30:679-680.
60. Flagg SD, Meador R, Hsia E, et al. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthritis Rheum 2005; 53:613-617.
61. Lauhio A, Leirisalo-Repo M, Lahdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991; 34:6-14.
62. Sadowski T, Steinmeyer J. Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes. J Rheumatol 2001; 28:336-340.
63. Smieja M, MacPherson DW, Kean W, et al. Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis. Ann Rheum Dis 2001; 60:1088-1094.
64. Wakefield D, McCluskey P, Verma M, et al. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 1999; 42:1894-1897.
65. Yli-KerttulaT, Luukkainen R, Yli-KerttulaU, et al. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 2000; 59:565-570.
66. Sieper J, Fendler C, Laitko S, et al. No benefit of long-term ciprofloxacin in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum 1999; 42:1386-1396.
67. Dreses-Werringloer U, Padubrin I, Jurgens-Saathoff B, et al. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 2000; 44:3288-3297.
68. Dreses-Werringloer U, Padubrin I, Zeidler H, Kohler L. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 2001; 45:3001-3008.
69. Zugel U, Kaufmann SH. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin Microbiol Rev 1999; 12:19-39. (Pubitemid 29055952)
70. Engel JN, Pollack J, Perara E, Ganem D. Heat shock response of murine Chlamydia trachomatis. J Bacteriol 1990; 172:6959-6972.
71. Amin AR, Attur MG, Thakker GD, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 1996; 93:14014-14019.
72. Retsema J, Fu W. Macrolides: structures and microbial targets. Int J Anti-microb Agents 2001; 18 (Suppl 1):S3-S10.
73. Carter JD, Valeriano J, Vasey FB. A prospective, randomized 9-month comparison of doxycycline vs. doxycycline and rifampin in undifferentiated spon-dyloarthritis: with special reference to Chlamydia-induced arthritis. J Rheumatol 2004; 31:1973-1980.
74. Carter JD, Espinoza LR, Inman RD, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis. Arthritis Rheum 2010; 62:1298-1307.